Boston Biomedica, Inc.
375 West Street
W. Bridgewater
Massachusetts
02379
U.S.A.
Phone:
508-580-1900
Fax:
508-580-1110
|
Boston Biomedica, Inc. provides products and services for the detection and monitoring of infectious diseases such as AIDS and Viral Hepatitis. BBI has three operating business units:
- BBI Diagnostics, an ISO 9001 certified manufacturer and supplier of quality control and diagnostics reagents used to increase the accuracy of in vitro diagnostic tests.
- BBI Biotech Research Laboratories, a research and development center providing R&D support for the other BBI business units, as well as contract research and repository services for the government, industry and other third parties.
- BBI Source Scientific, an ISO 9001 certified manufacturer of diagnostic instrumentation and medical devices.
In addition, BBI is conducting research and development in Pressure Cycling Technology (PCT) through its subsidiary BBI BioSeq, with the goal of introducing new solutions for a number of important healthcare issues, including: inactivation of pathogens in human plasma, extraction of nucleic acids, food safety, and genomics. BBI also maintains a passive investment in Panacos Pharmaceuticals, a privately held antiviral drug and vaccine development company recently spun-off from BBI, whose goal is to introduce new solutions for the treatment of infectious diseases.
Last Updated 8-28-01
Email:
Ownership:
Public
Web Site:
Boston Biomedica, Inc.
Employees:
275
Symbol: BBII
|